The role of high-throughput technologies in clinical cancer genomics

Author： Idris Saad F Ahmad Saif S Scott Michael A Vassiliou George S Hadfield James

ISSN： 1473-7159

Source： Expert Review of Molecular Diagnostics, Vol.13, Iss.2, 2013-03, pp. : 167-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The challenge of implementing high-throughput technologies in clinical trials

By Mocellin Simone Marincola Francesco M

Pharmacogenomics, Vol. 6, Iss. 4, 2005-06 ,pp. : 435-439

Future Medicine

Access to resources Recommend Favorite

New technologies for high-throughput analysis

By Liu Edison T

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 469-471

Future Medicine

Access to resources Recommend Favorite

High-Throughput Screening Technologies for Botulinum Neurotoxins

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 18, 2014-09 ,pp. : 2062-2080

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

Current Cancer Drug Targets, Vol. 4, Iss. 2, 2004-03 ,pp. : 111-124

Bentham Science Publishers

Access to resources Recommend Favorite

Exploiting High-Throughput Ion Channel Screening Technologies in Integrated Drug Discovery

Current Pharmaceutical Design, Vol. 12, Iss. 4, 2006-02 ,pp. : 397-406

Bentham Science Publishers

Access to resources Recommend Favorite